Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-018105
Date:2021-05-03
Issuer: ELEDON PHARMACEUTICALS, INC. (ELDN)
Original Submission Date:

Reporting Person:

SMITH BRYAN E.
C/O ELEDON PHARMACEUTICALS, INC.
19900 MACARTHUR BLVD., SUITE 550 IRVINE, CA 92612

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 9.91 2021-05-03 deemed execution date A 158,500 (a) 2031-05-03 common stock 158,500 $9.91 158,500 direct
Footnotes
IDfootnote
f1 this option represents a right to purchase up to 158,500 shares of common stock, which option vests with respect to 39,625 shares on may 3, 2022, and then with respect to 6.25% of the underlying shares quarterly over the three year period ending may 3, 2025.

Elevate your investments